Difficulty: Medium
Average Score: 82%
Practice
Phenytoin
Correct answer
D
Rationale
Phenytoin is a commonly used antiepileptic drug that works by stabilizing neuronal membranes. The correct answer, D) Steady-state mean plasma concentrations vary disproportionately with dose, is accurate because phenytoin exhibits non-linear pharmacokinetics. This means that as the dose increases, the plasma concentration does not increase proportionally, leading to variations in steady-state levels.
Option A) Is 20-30% bound to albumin is incorrect because phenytoin is highly protein-bound (usually around 90%), not 20-30%. Option B) Is the drug of choice for absence seizures is incorrect as ethosuximide is typically the preferred choice for treating absence seizures. Option C) Undergoes flow-limited elimination is incorrect because phenytoin undergoes saturable metabolism in the liver, leading to dose-dependent kinetics rather than flow-limited elimination.
Understanding the pharmacokinetic properties of phenytoin is crucial for healthcare professionals to ensure appropriate dosing and monitoring. Non-linear kinetics can result in unexpected changes in plasma concentrations with dose adjustments, emphasizing the need for close monitoring and individualized dosing regimens to optimize therapeutic outcomes while minimizing adverse effects.
Option A) Is 20-30% bound to albumin is incorrect because phenytoin is highly protein-bound (usually around 90%), not 20-30%. Option B) Is the drug of choice for absence seizures is incorrect as ethosuximide is typically the preferred choice for treating absence seizures. Option C) Undergoes flow-limited elimination is incorrect because phenytoin undergoes saturable metabolism in the liver, leading to dose-dependent kinetics rather than flow-limited elimination.
Understanding the pharmacokinetic properties of phenytoin is crucial for healthcare professionals to ensure appropriate dosing and monitoring. Non-linear kinetics can result in unexpected changes in plasma concentrations with dose adjustments, emphasizing the need for close monitoring and individualized dosing regimens to optimize therapeutic outcomes while minimizing adverse effects.